Viridian Therapeutics, Inc. VRDN Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s total liabilities & equity?
- Viridian Therapeutics, Inc. (VRDN) reported total liabilities & equity of $789.02M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Viridian Therapeutics, Inc.'s total liabilities & equity increased by 19.4% year-over-year, from $660.98M to $789.02M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s total liabilities & equity has grown at a 46.9% compound annual growth rate (CAGR), from $131.26M to $899.42M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.